May 13, 2022 / 07:30AM GMT
Presentation
May 13, 2022 / 07:30AM GMT
=====================
Corporate Participants
=====================
* Haruo Naito
Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director
* Ivan Cheung
Eisai Co., Ltd. - Senior VP & President of Neurology Business Group Global Alzheimer's Disease Officer
* Ryohei Yanagi
Eisai Co., Ltd. - Executive VP & CFO
* Takashi Owa
Eisai Co., Ltd. - Senior VP, President & Chief Discovery Officer of Oncology Business Group - Japan and Asia Medical
* Teruyuki Masaka
Eisai Co., Ltd. - VP & Chief Planning Officer
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Takashi Akahane
Tokai Tokyo Research Institute Co., Ltd. - Senior Analyst
============
Eisai Co Ltd
(HAM:EII)
€
21.13
+0.25 (+1.2%)
Market Cap: 6.13 Bil
Enterprise Value: 5.94 Bil
PE Ratio: 29.18
PB Ratio: 1.25
GF Score: 64/100 Full Year 2022 Eisai Co Ltd Earnings Presentation Transcript
May 13, 2022 / 07:30AM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot